Simplex Trading
FENC icon

Simplex Trading’s Fennec Pharmaceuticals FENC Stock Holding History

Simplex Trading’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-300
Closed -$1K – 8953
2025
Q1 		$1K Buy
+300
New +$1.93K ﹤0.01% 8199
2023
Q4 		– Sell
-4,000
Closed -$30K – 9084
2023
Q3 		$30K Buy
4,000
+1,000
+33% +$8.14K ﹤0.01% 6253
2023
Q2 		$26K Buy
3,000
+2,400
+400% +$20K ﹤0.01% 6491
2023
Q1 		$4K Hold
600
– – ﹤0.01% 8164
2022
Q4 		$5K Sell
600
-87,300
-99% -$772K ﹤0.01% 8046
2022
Q3 		$711K Buy
87,900
+81,300
+1,232% +$558K ﹤0.01% 3063
2022
Q2 		$37K Buy
6,600
+800
+14% +$4.64K ﹤0.01% 6877
2022
Q1 		$32K Buy
5,800
+3,400
+142% +$17.1K ﹤0.01% 7694
2021
Q4 		$10K Buy
+2,400
New +$17.9K ﹤0.01% 9021
2020
Q3 		– Sell
-4
Closed -$3K – 7991
2020
Q2 		$3K Buy
+4
New +$30 ﹤0.01% 7140

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Simplex Trading's FENC Position: Q4 2025 in Review

Simplex Trading sold out of Fennec Pharmaceuticals (FENC) in Q4 2025, closing a stake of 21,270 shares — an estimated $175K sold.

Simplex Trading first reported a position in FENC in Q3 2019 and held it in 15 quarters. The position peaked at $199K in Q3 2025. 96 funds tracked by Wall St. Rank hold FENC as of Q4 2025.

  • Simplex Trading reported no remaining Fennec Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 21,270 Fennec Pharmaceuticals shares in Q4 2025, an estimated $175K.
  • Simplex Trading first reported a position in Fennec Pharmaceuticals in Q3 2019 and held it in 15 quarters.
  • Simplex Trading's Fennec Pharmaceuticals position peaked at $199K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.